DocMorris AG (DOCM.SW) stock: key figures, P/E, revenue and dividend

Health Care · Switzerland · ISIN CH0042615283

Price
16.03 CHF
Market cap
817.23 m CHF
P/E (2025)
–
P/S (2025)
0.73
Dividend yield
0.00 %
Net margin
-11.92 %
Return on equity (ROE)
-32.75 %
Return on assets (ROA)
-16.23 %

DocMorris AG financials

Fiscal year20242025
Revenue1.02 bn CHF1.12 bn CHF
Gross profit216.00 m CHF105.00 m CHF
Operating income-103.09 m CHF-98.40 m CHF
EBIT-104.00 m CHF-84.00 m CHF
Net income-97.00 m CHF-134.00 m CHF
Diluted EPS – continuing operations-4.05 CHF-2.60 CHF

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About DocMorris AG

DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.